Performance of first-trimester combined test for Down syndrome in different maternal age groups: reason for adjustments in screening policy?

Engels, Melanie A J; Heijboer, A C; Blankenstein, Marinus A; van Vugt, John M G

Engels, Melanie A J; Heijboer, A C; Blankenstein, Marinus A; van Vugt, John M G.

Affiliation

Engels MA; Department of Obstetrics and Gynecology, VU University Medical Center, Amsterdam, The Netherlands. m.engels@vumc.nl

Prenat Diagn ; 31(13): 1241-5, 2011 Dec.

Article in En | MEDLINE | ID: mdl-22025131

Subject(s)

Down Syndrome/diagnosis; Pregnancy Trimester, First; Prenatal Diagnosis/methods; Adult; Age Factors; Biomarkers/blood; Biomarkers/metabolism; Chorionic Gonadotropin, beta Subunit, Human/blood; Down Syndrome/blood; False Positive Reactions; Female; Humans; Middle Aged; Nuchal Translucency Measurement; Pregnancy; Pregnancy-Associated Plasma Protein-A/metabolism; Retrospective Studies; Risk Assessment; Sensitivity and Specificity

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Pregnancy Trimester, First / Prenatal Diagnosis / Down Syndrome Type of study: Diagnostic_studies / Etiology_studies / Evaluation_studies / Observational_studies / Risk_factors_studies / Screening_studies Limits: Adult / Female / Humans / Middle aged / Pregnancy Language: En Year: 2011 Type: Article

Fulltext

XML

PubMed Links

Search on Google